Kaiser Permanente- Modesto MOB II — Modesto, California

Kaiser Permanente- Modesto MOB II is a clinical research site located in Modesto, California, United States 95356.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente- Modesto MOB II has participated in 34 clinical trials with 32 currently active.

Therapeutic areas: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Modesto

Browse all research sites in California · View every site in Modesto

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente- Modesto MOB II?

Kaiser Permanente- Modesto MOB II has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente- Modesto MOB II conducted?

Kaiser Permanente- Modesto MOB II has 34 clinical trials on record, with 32 currently active. Their work covers Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma.

Is Kaiser Permanente- Modesto MOB II accredited by Crixeo Clinical Trials?

Kaiser Permanente- Modesto MOB II has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente- Modesto MOB II?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.